Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC
Clinical trial NCT02337530 · COMPLETED
Trial details
- NCT number
- NCT02337530
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-26
- Primary completion
- 2017-10-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.